Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Biological Cybernetics|January 6, 2007
Spatial symmetries in vestibular projections to the uvula-nodulusIsaac Z Foster, Douglas A Hanes, Neal H Barmack, et al.Disability and Rehabilitation|February 14, 2024
Integrative medicine for hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS): a feasibility studySara E Guedry, Blake O Langley, Kerry Schaefer, et al.Global Advances in Health and Medicine|August 7, 2019
Effect of a Nutrition Support Formula in Adults With Inflammatory Bowel Disease: A Pilot StudyJennifer J Ryan, Douglas A Hanes, Ryan D Bradley, et al.Digestive Diseases and Sciences|November 25, 2025
Impact of Patient Positioning and Endotracheal Intubation During ERCP: Insights from a Large DatabaseDivyanshoo R Kohli, Nishant Puri, Douglas A Hanes, et al.American Journal of Surgery|November 13, 2025
Impact of non-metropolitan residence on survival for gastric neuroendocrine tumorsHilary R Keller, Douglas A Hanes, Jillian K McCabe, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 24, 2024
Socially vulnerable patients are more likely to fail outpatient management of symptomatic cholelithiasisUdai S Sibia, John R Klune, Cristina B Feather, et al.Nursing Research|December 30, 2021
Parental Worrying, Family Functioning, and Quality of Life During the COVID-19 PandemicAsma A Taha, Najood Ghazi Azar, Aaron M Eisen, et al.Journal of Alternative and Complementary Medicine (New York, N.Y.)|October 13, 2018
Impact of a Short-Term Naturopathic Whole-Foods-Based Nutrition Education Intervention on Dietary Behavior and Diabetes Risk Markers: A Pilot StudyKimberly M Tippens, Andrew Erlandsen, Douglas A Hanes, et al.American Journal of Surgery|November 13, 2025
Male or female sex stratified by age does not impact survival in patients with metastatic melanoma receiving immunotherapyHilary R Keller, Douglas A Hanes, Danny Lascano, et al.Cancer Medicine|November 29, 2024
Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph NodeShu-Ching Chang, Kristel Lourdault, Gary L Grunkemeier, et al.Pageof 3